Scientists provide insights into incurable brain disease

March 22, 2013, University of Queensland

(Medical Xpress)—Queensland Institute of Medical Research, Griffith University and University of Queensland scientists researching a degenerative brain disease have developed a new way to understand its progression and safely test potential treatments.

The researchers have managed to generate Ataxia-telangiectasia (A-T) patients' nasal in the laboratory.

UQ Centre for Clinical Research Professor Martin Lavin, head of QIMR's Radiation Biology and Oncology Laboratory, said the breakthrough meant scientists could study exactly what was happening in a patient's brain.

"And we think it means we can make a good contribution to coming up with a drug, to at least slow down the progress of the disease," Professor Lavin said.

Ataxia-telangiectasia (A-T) is an incurable, that leads to severe disabilities, a , and an increased risk of cancer.

Children who have the are usually wheelchair-bound by their teens and rarely live beyond early adulthood.

Professor Lavin's team collaborated with Professor Alan Mackay-Sim from the Eskitis Institute for at Griffith University to generate the stem cells from the olfactory organ in the nose, which are capable of changing into a wide range of specialised cell types.

These are known as olfactory neurosphere-derived (ONS) cells.

The ONS cells help scientists better understand how the condition develops, and allows them to screen a patient for any new drugs which might slow down the progression of the disease.

"These cells from the don't need to manipulated, or have viruses or genes added to them, they simply grow in the lab," Professor Lavin said.

"And it provides us with very individualised information about a patient.

It means we can screen them for any potential treatments, because we have their exact cells which can be converted into brain or other cell types, and they provide a specific guide to how the disease has taken hold in their brain."

The QIMR team have also developed a rat model for A-T, which mimics the disease's effects and are also in the process of making ONS cells from the mutant rats with the Griffith University team.

Future research will involve returning "corrected" ONS back into the rat model's brain, to see whether the disease progression can be slowed.

"If those experiments work, then there will be the potential to correct the defects in the patients' stem cells, and transplant them back into a person's brain as neurons.

It's just one of the ways we're trying to tackle a disease which attacks on so many fronts."

Brisbane has the only Ataxia-telangiectasia clinic in the southern hemisphere, lead by UQCCR researcher Dr Kate Sinclair and a team of clinicians from UQCCR and the Royal Children's Hospital who also contributed to this study.

The research abstract is available to download in the current issue of Human Molecular Genetics.

Explore further: Step closer to understanding childhood degenerative brain disease

Related Stories

Step closer to understanding childhood degenerative brain disease

July 3, 2012
(Medical Xpress) -- Researchers at the Australian Institute for Bioengineering and Nanotechnology (AIBN) are a step closer to understanding and combating the degenerative brain disease ataxia-telangiectasia.

In schizophrenia research, a path to the brain through the nose

January 25, 2012
A significant obstacle to progress in understanding psychiatric disorders is the difficulty in obtaining living brain tissue for study so that disease processes can be studied directly. Recent advances in basic cellular neuroscience ...

Stem cells reverse disease in a model of Parkinson's disease

May 16, 2011
In a new study to be published in the Journal of Clinical Investigation, researchers compared the ability of cells derived from different types of human stem cell to reverse disease in a rat model of Parkinson disease and ...

Speeding up Huntington's research

July 9, 2012
(Medical Xpress) -- Human brain cells showing aspects of Huntington’s Disease have been developed, opening up new research pathways for treating the fatal disorder.

Cancer drug a possible treatment for multiple sclerosis

February 21, 2013
(Medical Xpress)—A drug that is currently used for cancer can relieve and slow down the progression of the autoimmune disease multiple sclerosis (MS) in rats, according to a new study published in PLOS ONE. The discovery, ...

Recommended for you

Discovery of the 'pioneer' that opens the genome

January 23, 2018
Our genome contains all the information necessary to form a complete human being. This information, encoded in the genome's DNA, stretches over one to two metres long but still manages to squeeze into a cell about 100 times ...

Researchers identify gene responsible for mesenchymal stem cells' stem-ness'

January 22, 2018
Many doctors, researchers and patients are eager to take advantage of the promise of stem cell therapies to heal damaged tissues and replace dysfunctional cells. Hundreds of ongoing clinical trials are currently delivering ...

Genes contribute to biological motion perception and its covariation with autistic traits

January 22, 2018
Humans can readily perceive and recognize the movements of a living creature, based solely on a few point-lights tracking the motion of the major joints. Such exquisite sensitivity to biological motion (BM) signals is essential ...

Peers' genes may help friends stay in school, new study finds

January 18, 2018
While there's scientific evidence to suggest that your genes have something to do with how far you'll go in school, new research by a team from Stanford and elsewhere says the DNA of your classmates also plays a role.

Two new breast cancer genes emerge from Lynch syndrome gene study

January 18, 2018
Researchers at Columbia University Irving Medical Center and NewYork-Presbyterian have identified two new breast cancer genes. Having one of the genes—MSH6 and PMS2—approximately doubles a woman's risk of developing breast ...

A centuries-old math equation used to solve a modern-day genetics challenge

January 18, 2018
Researchers developed a new mathematical tool to validate and improve methods used by medical professionals to interpret results from clinical genetic tests. The work was published this month in Genetics in Medicine.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.